Erlmeier F, Agaimy A, Hartmann A, Stöhr CG (2019)
Publication Type: Journal article, Review article
Publication year: 2019
Book Volume: 25
Pages Range: 497-511
Journal Issue: 6
DOI: 10.1007/s00761-019-0571-8
Background: The latest edition of the WHO classification of urogenital tumors was published in January 2016. Numerous innovations have been included following the decisions of the consensus conference held in Zurich in March 2015. This review article presents the histopathology and molecular pathology of renal tumors defined in the 2016 WHO classification. Results and conclusions: In recent years knowledge about the morphology and the biological behavior of kidney tumors has steadily improved. In particular, the expanded molecular knowledge and improved data from clinicopathological studies of these tumors have led to the recognition of new entities by the WHO. These include, among others, succinate dehydrogenase B deficiency-associated renal cell carcinoma, hereditary leiomyomatosis-associated renal cell cancer, tubulocystic renal cell carcinoma and clear cell papillary renal cell carcinoma.
APA:
Erlmeier, F., Agaimy, A., Hartmann, A., & Stöhr, C.G. (2019). Pathology and molecular pathology of renal cell cancer Pathologie und Molekularpathologie des Nierenzellkarzinoms. Onkologe, 25(6), 497-511. https://doi.org/10.1007/s00761-019-0571-8
MLA:
Erlmeier, Franziska, et al. "Pathology and molecular pathology of renal cell cancer Pathologie und Molekularpathologie des Nierenzellkarzinoms." Onkologe 25.6 (2019): 497-511.
BibTeX: Download